nco 700 has been researched along with calpain in 5 studies
| Studies (nco 700) | Trials (nco 700) | Recent Studies (post-2010) (nco 700) | Studies (calpain) | Trials (calpain) | Recent Studies (post-2010) (calpain) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 7,019 | 25 | 2,422 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iizuka, K; Kawaguchi, H; Kitabatake, A; Yasuda, H | 1 |
| Morita, M; Okaimatsuo, Y; Shin, WS; Sugimoto, T; Toyo-oka, T | 1 |
| Morita, M; Toyo-oka, T | 1 |
| Iizuka, K; Kawaguchi, H; Takano, H; Yasuda, H | 1 |
| Kamishiro, T; Masaki, M; Masaki, T; Toyo-oka, T | 1 |
1 review(s) available for nco 700 and calpain
| Article | Year |
|---|---|
Contribution of calcium-activated neutral protease to the degradation process of ischemic heart.
Topics: Animals; Calpain; Coronary Disease; Dogs; Humans; Muscle Proteins; Myocardium; Piperazines; Platelet Aggregation; Protease Inhibitors; Rabbits | 1991 |
4 other study(ies) available for nco 700 and calpain
| Article | Year |
|---|---|
The role of calcium activated neutral protease on myocardial cell injury in hypoxia.
Topics: Animals; Calcium-Binding Proteins; Calpain; Cell Hypoxia; Cells, Cultured; Glycoproteins; In Vitro Techniques; Myocardium; Piperazines; Protease Inhibitors; Rats | 1992 |
[Cardiovascular diseases and enzyme inhibitors].
Topics: Animals; Blood Platelets; Calpain; Cardiovascular Diseases; Endothelins; Humans; Piperazines; Platelet Aggregation Inhibitors; Serotonin | 1991 |
Platelet aggregation induced by platelet-activating factor is suppressed by cystine protease inhibitor.
Topics: Animals; Blood Platelets; Calpain; Cathepsin B; In Vitro Techniques; Indomethacin; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Protease Inhibitors; Rabbits; Serotonin | 1991 |
Reduction of experimentally produced acute myocardial infarction size by a new synthetic inhibitor, NCO-700, against calcium-activated neutral protease.
Topics: Animals; Calpain; Male; Myocardial Infarction; Myocardium; Piperazines; Protease Inhibitors; Rabbits | 1982 |